Haruhiko Cho

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang et al. · The Lancet · 2018 · 1.3K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Body Weight Loss After Surgery is an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer

Toru Aoyama, Takaki Yoshikawa, Junya Shirai et al. · Annals of Surgical Oncology · 2012 · 189 citations

Medicine, Oncology, Surgery +13

Five-Year Survival Outcomes of Laparoscopy-Assisted vs Open Distal Gastrectomy for Advanced Gastric Cancer

Tsuyoshi Etoh, Tetsuji Ohyama, Shinichi Sakuramoto et al. · JAMA Surgery · 2023 · 189 citations · Full text

Medicine, Oncology, Surgery +17

Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery

Takanobu Yamada, Tsutomu Hayashi, Haruhiko Cho et al. · Gastric Cancer · 2011 · 165 citations · Full text

Medicine, Perioperative Medicine, Surgery +14

Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer

Toru Aoyama, Taiichi Kawabe, Hirohito Fujikawa et al. · Annals of Surgical Oncology · 2014 · 146 citations

Medicine, Nutrition, Oncology +16